Overview: Y-Chromosome Microdeletion PCR TestIntroduction: The Y-Chromosome Microdeletion PCR Test detects Y-chromosome microdeletions to diagnose male infertility, causing conception issues. Aligned with 2023 ASRM guidelines, it uses PCR for high specificity, supporting genetic screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in molecular pathology for patients with suspected male infertility.
Other Names: Y-Chromosome Deletion Assay, AZF Deletion Test.
FDA Status: Laboratory-developed test (LDT), meeting molecular pathology standards for diagnostic accuracy.
Historical Milestone: Y-chromosome microdeletion testing began in the 1990s with infertility research. PCR methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects Y-chromosome microdeletions to diagnose male infertility, guides treatment, and evaluates patients with conception issues.
Test Parameters: 1. Y-Chromosome Microdeletions
Pretest Condition: No fasting required. Collect whole blood, buccal swab, or saliva. Report history of infertility or reproductive issues.
Specimen: Whole Blood (EDTA, 2-5 mL), Buccal Swab (sterile swab, 1-2 swabs), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document infertility, low sperm count, or history of reproductive issues. Include current medications or hormonal treatments.
Consent: Written consent required, detailing the tests purpose, infertility implications, and risks of sample collection.
Procedural Considerations: Uses PCR to detect Y-chromosome microdeletions (e.g., AZFa, AZFb, AZFc). Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for infertility diagnosis.
Factors Affecting Result Accuracy: Low DNA yield or contamination can affect results. Sample quality impacts specificity.
Clinical Significance: Y-chromosome microdeletions confirm genetic infertility, guiding assisted reproductive techniques or counseling. Normal results may require karyotyping.
Specialist Consultation: Consult a reproductive endocrinologist or geneticist for result interpretation and treatment planning.
Additional Supporting Tests: Semen analysis, karyotyping, or hormonal testing to confirm infertility diagnosis.
Test Limitations: Specific to Y-chromosome defects; other infertility causes may be missed. Sample quality affects sensitivity.
References: ASRM Infertility Guidelines, 2023; Human Reproduction, Krausz C, 2022.
